Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
暂无分享,去创建一个
Emile Daraï | Emmanuel Barranger | Khaldoun Kerrou | Y. Petegnief | E. Daraï | E. Barranger | Yolande Petegnief | A. Cortez | K. Kerrou | Annie Cortez | Emmanuel David-Montefiore | E. David-Montefiore
[1] R. Essner,et al. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. , 2001, The Journal of surgical research.
[2] Taylor Murray,et al. Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.
[3] R. Wahl,et al. PET-CT in recurrent ovarian cancer: initial observations. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[4] K. Togashi,et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. , 2001, AJR. American journal of roentgenology.
[5] E. Martin,et al. 18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. , 2001, The Journal of surgical research.
[6] Elliot K Fishman,et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. , 2003, Gynecologic oncology.
[7] E. Darai,et al. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma , 2003, Cancer.
[8] S. Rubin,et al. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. , 1989 .
[9] J S Karp,et al. Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] C. Meltzer,et al. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. , 2002, Gynecologic Oncology.
[11] E. Yoshikawa,et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[12] E. Yordan,et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G. V. von Schulthess,et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma , 2000, European Radiology.
[14] E. Martin,et al. Correlative Whole-Body FDG-PET and Intraoperative Gamma Detection of FDG Distribution in Colorectal Cancer. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[15] R. Bast,et al. Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. , 1985, American journal of obstetrics and gynecology.
[16] M. Deavers,et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.